Clinical Trial: Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: We aimed to compare efficacy and safety of combination therapy with oral ofloxacin, 400 mg twice daily, plus oral metronidazole, 500 mg twice daily, for 14 days, with moxifloxacin monotherapy, 400 mg once daily, for 14 days

Detailed Summary:
Sponsor: Istanbul Bakirkoy Maternity and Children Diseases Hospital

Current Primary Outcome: Clinically cure [ Time Frame: 21 Days ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Microbiological cure [ Time Frame: 21 Days ]

Original Secondary Outcome: Same as current

Information By: Istanbul Bakirkoy Maternity and Children Diseases Hospital

Dates:
Date Received: February 16, 2013
Date Started: June 2010
Date Completion:
Last Updated: August 27, 2013
Last Verified: August 2013